AKT1 and neoplasm: In support of the lack of a role for AKT in lapatinib-induced growth in vitro shown above, immunoblot analyses of mouse tumours showed that in CWR22 tumours, lapatinib suppressed AKT phosphorylation at S473, whereas ERK phosphorylation at T202/Y204 was not altered (Fig. S5B).